We're sorry, but BRENDA doesn't work properly without JavaScript. Please make sure you have JavaScript enabled in your browser settings.
Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
EC Tree
IUBMB Comments Also acts on dATP to form 3',5'-cyclic dAMP. Requires pyruvate. Activated by NAD+ in the presence of EC 2.4.2.31 NAD(P)+---arginine ADP-ribosyltransferase.
The taxonomic range for the selected organisms is: Escherichia coli The enzyme appears in selected viruses and cellular organisms
Synonyms
adenylate cyclase, adenylyl cyclase, adenyl cyclase, pituitary adenylate cyclase, edema factor, adenylylcyclase, soluble adenylyl cyclase, adenylate cyclase toxin, adcy5, aciii,
more
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
class I adenylate cyclase
-
3',5'-cyclic AMP synthetase
-
-
-
-
Adenylate cyclase, olfactive type
-
-
-
-
Adenylyl cyclase type 10
-
-
-
-
ATP pyrophosphate-lyase
-
-
-
-
Ca(2+)-inhibitable adenylyl cyclase
-
-
-
-
Ca(2+)/calmodulin activated adenylyl cyclase
-
-
-
-
cyclase, adenylate
-
-
-
-
adenylyl cyclase
-
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
P-O bond cleavage
-
-
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ATP diphosphate-lyase (cyclizing; 3',5'-cyclic-AMP-forming)
Also acts on dATP to form 3',5'-cyclic dAMP. Requires pyruvate. Activated by NAD+ in the presence of EC 2.4.2.31 NAD(P)+---arginine ADP-ribosyltransferase.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ATP
3',5'-cyclic-AMP + diphosphate
ATP
3',5'-cAMP + diphosphate
additional information
?
-
ATP
3',5'-cyclic-AMP + diphosphate
-
-
-
?
ATP
3',5'-cyclic-AMP + diphosphate
S103 is important for substrate binding docking to the gamma-phosphate group of ATP
-
-
?
ATP
3',5'-cAMP + diphosphate
-
-
-
-
?
ATP
3',5'-cAMP + diphosphate
-
-
-
r
additional information
?
-
structure-function relationship, overview
-
-
?
additional information
?
-
-
structure-function relationship, overview
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
ATP
3',5'-cyclic-AMP + diphosphate
-
-
-
?
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Mg2+
the class I enzyme shows a requirement for free metal ions in addition to the MgATP2- complex, operating with a two-metal-ion mechanism in analogy to class II and calss III enzymes. The native enzyme shows very little activity when the concentration of Mg2+ is much lower than that of ATP, and activity rises strongly when the concentration of Mg2+ exceeds that of ATP
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
2'(3')-O-(N-methylanthraniloyl)-ADP
slight competitive inhibition
2'(3')-O-(N-methylanthraniloyl)-AMP
slight competitive inhibition
2'(3')-O-(N-methylanthraniloyl)-ATP
competitive
3-[(9-oxo-9H-fluorene-1-carbonyl)-amino]-benzoic acid
-
-
ATP
-
high concentrations
Co2+
-
high concentrations
pyridoxal 5'-phosphate
-
-
Ribonucleoside triphosphates
-
-
additional information
inhibition of mutant catalytic domains by 2'(3')-O-(N-methylanthraniloyl)-modified nucleotides is reduced compared to the wild-type catalytic domain Cya2-446, overview
-
additional information
-
inhibition of mutant catalytic domains by 2'(3')-O-(N-methylanthraniloyl)-modified nucleotides is reduced compared to the wild-type catalytic domain Cya2-446, overview
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.153
ATP
pH 8.0, 37°C, recombinant catalytic domain mutant Y394A, 10 mM Mg2+
0.165
ATP
pH 8.0, 37°C, recombinant catalytic domain mutant W374A, 10 mM Mg2+
0.168
ATP
pH 8.0, 37°C, recombinant catalytic domain mutant W249A, 10 mM Mg2+
0.201
ATP
pH 8.0, 37°C, recombinant catalytic domain mutant K136A, 10 mM Mg2+
0.216
ATP
pH 8.0, 37°C, recombinant catalytic domain mutant E242A, 10 mM Mg2+
0.259
ATP
pH 8.0, 37°C, recombinant catalytic domain mutant K253A, 10 mM Mg2+
0.27
ATP
pH 8.0, 37°C, recombinant catalytic domain, 10 mM Mg2+
0.275
ATP
pH 8.0, 37°C, recombinant catalytic domain mutant E185A, 10 mM Mg2+
0.284
ATP
pH 8.0, 37°C, recombinant catalytic domain mutant K260A, 10 mM Mg2+
0.33
ATP
pH 8.0, 37°C, recombinant catalytic domain mutant S113A, 10 mM Mg2+
0.398
ATP
pH 8.0, 37°C, recombinant catalytic domain mutant T189A, 10 mM Mg2+
0.46
ATP
pH 8.0, 37°C, recombinant catalytic domain mutant R19A, 10 mM Mg2+
0.533
ATP
pH 8.0, 37°C, recombinant catalytic domain mutant S106A, 10 mM Mg2+
0.682
ATP
pH 8.0, 37°C, recombinant catalytic domain mutant K332A, 10 mM Mg2+
4.7
ATP
pH 8.0, 37°C, recombinant catalytic domain mutant S103A, 10 mM Mg2+
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.05
2'(3')-O-(N-methylanthraniloyl)-ATP
pH 8.0, 37°C, versus ATP, wild-type catalytic domain Cya2-446
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
0.281
purified recombinant catalytic domain mutant S106A, 10 mM Mg2+
0.396
purified recombinant catalytic domain mutant K136A, 10 mM Mg2+
0.48
purified recombinant catalytic domain mutant W374A, 10 mM Mg2+
0.513
purified recombinant catalytic domain mutant Y394A, 10 mM Mg2+
0.526
purified recombinant catalytic domain mutant K253A, 10 mM Mg2+
0.614
purified recombinant catalytic domain mutant R19A, 10 mM Mg2+
0.665
purified recombinant catalytic domain, 10 mM Mg2+
0.752
purified recombinant catalytic domain mutant E242A, 10 mM Mg2+
0.778
purified recombinant catalytic domain mutant W249A, 10 mM Mg2+
additional information
the specific activity of the catalytic domain fragment Cya2-446 and of the holoenzyme is independent of the protein concentration
additional information
-
the specific activity of the catalytic domain fragment Cya2-446 and of the holoenzyme is independent of the protein concentration
additional information
-
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
8.5 - 9
recombinant catalytic domain Cya2-446
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
47
recombinant catalytic domain Cya2?446
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
class I AC gene
UniProt
brenda
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
-
-
brenda
-
-
brenda
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
92000 - 110000
-
sucrose density gradient centrifugation
92000 - 110000
-
gel filtration, SDS-PAGE
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
additional information
structure-function relationship, overview
additional information
-
structure-function relationship, overview
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
D114A
site-directed mutagenesis, the almost inactive mutant shows highly reduced activity compared to the wild-type enzyme
D116A
site-directed mutagenesis, the almost inactive mutant shows highly reduced activity compared to the wild-type enzyme
D300A
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
E185A
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
E242A
site-directed mutagenesis, the mutant shows reduced Vmax and altered Km compared to the wild-type enzyme
K136A
site-directed mutagenesis, the mutant shows reduced Vmax and altered Km compared to the wild-type enzyme
K253A
site-directed mutagenesis, the mutant shows reduced Vmax and altered Km compared to the wild-type enzyme
K260A
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
K264A
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
K332A
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
R19A
site-directed mutagenesis, the mutant shows reduced Vmax and altered Km compared to the wild-type enzyme
S103A
site-directed mutagenesis, the mutant has a 17fold higher Km for ATP compared to the wild-type enzyme, and the mutation causes a marked reduction of discrimination between ATP- and ADP- or AMP-derived inhibitors
S106A
site-directed mutagenesis, the mutation reduces the mutant activity to 25% of the wild-type enzyme activity, kinetic analysis show a 58% reduction of the Vmax and a doubling of the Km compared to the wild-type enzyme
S113A
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
T189A
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
W118A
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
W200A
site-directed mutagenesis, the mutant shows highly reduced activity compared to the wild-type enzyme
W249A
site-directed mutagenesis, the mutant shows reduced Vmax and altered Km compared to the wild-type enzyme
W374A
site-directed mutagenesis, the mutant shows reduced Vmax and altered Km compared to the wild-type enzyme
Y394A
site-directed mutagenesis, the mutant shows reduced Vmax and altered Km compared to the wild-type enzyme
D414B
-
mutant does not show increased cAMP levels
G463D
-
mutant does not show increased cAMP levels
R188H
-
mutant does not show increased cAMP levels
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
stabilized by ATP or at -20°C as an ammonium sulfate precipitate or in 50% glycerol
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
-20°C (NH4)2SO4 precipitate, 50% glycerol, 5 mM ATP, 3 months
-
liquid N2, several months
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
recombinant wild-type and mutant catalytic domain Cya2-446 from strain BL21(DE3) by nickel affinity chromatography
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
class I AC gene, overexpression of wild-type and mutant catalytic domain, residues 2-446, i.e. Cya2-446, in strain BL21(DE3)
overexpression in Escherichia coli
-
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Yang, J.K.; Epstein, W.
Purification and characterization of adenylate cyclase from Escherichia coli K12
J. Biol. Chem.
258
3750-3758
1983
Glutamicibacter nicotianae, Escherichia coli
brenda
Janecek, J.; Naprstek, J.; Dobrova, Z.; Jiresova, M.; Spizek, J.
Characterization of adenylate cyclase from Escherichia coli
Folia Microbiol. (Praha)
25
361-368
1980
Glutamicibacter nicotianae, Escherichia coli
brenda
Tao, M.
Preparation and properties of adenylate cyclase from Escherichia coli
Methods Enzymol.
38C
155-160
1974
Glutamicibacter nicotianae, Escherichia coli
brenda
Ide, M.
Adenyl cyclase of bacteria
Arch. Biochem. Biophys.
144
262-268
1971
Alcaligenes faecalis, Arthrobacter citreus, Arthrobacter globiformis, Glutamicibacter nicotianae, Rhodococcus equi, Escherichia coli, Pectobacterium carotovorum, Micrococcus flavus, Micrococcus luteus, Nocardia erythropolis
-
brenda
Reddy, P.; Peterkofsky, A.; McKenney, K.
Hyperexpression and purification of Escherichia coli adenylate cyclase using a vector designed for expression of lethal gene products
Nucleic Acids Res.
17
10473-10488
1989
Escherichia coli
brenda
Crasnier, M.; Danchin, A.
Characterization of Escherichia coli adenylate cyclase mutants with modified regulation
J. Gen. Microbiol.
136
1825-1831
1990
Escherichia coli
brenda
Linder, J.U.
Class III adenylyl cyclases: molecular mechanisms of catalysis and regulation
Cell. Mol. Life Sci.
63
1736-1751
2006
Bacillus anthracis, Bordetella pertussis, Saccharomyces cerevisiae, Caenorhabditis elegans, Chlamydomonas reinhardtii, Chloroflexus aurantiacus, Dictyostelium discoideum, Drosophila melanogaster, Escherichia coli, Euglena gracilis, Mus musculus, Myxococcus xanthus, Pseudomonas aeruginosa, Rattus norvegicus, Sinorhizobium meliloti, Schizosaccharomyces pombe, Arthrospira platensis, Trypanosoma brucei, Ustilago maydis, Yersinia enterocolitica, Mycobacterium tuberculosis (P9WQ35), Nostoc sp. PCC 7120 = FACHB-418 (Q7A2D9), Nostoc sp. PCC 7120 = FACHB-418 (Q8YMH0), Nostoc sp. PCC 7120 = FACHB-418 (Q8YVS0), Mycobacterium tuberculosis H37Rv (P9WQ35)
brenda
Linder, J.U.
Structure-function relationships in Escherichia coli adenylate cyclase
Biochem. J.
415
449-454
2008
Escherichia coli (P00936), Escherichia coli
brenda
Moen, S.T.; Blumentritt, C.A.; Slater, T.M.; Patel, S.D.; Tutt, C.B.; Estrella-Jimenez, M.E.; Pawlik, J.; Sower, L.; Popov, V.L.; Schein, C.H.; Gilbertson, S.R.; Peterson, J.W.; Torres, A.G.
Testing the efficacy and toxicity of adenylyl cyclase inhibitors against enteric pathogens using in vitro and in vivo models of infection
Infect. Immun.
78
1740-1749
2010
Escherichia coli
brenda
Transporter Classification Database (TCDB):
8.A.85.1.4